Distinct gut microbial compositional and functional changes associated with impaired inhibitory control in patients with cirrhosis

References

• Cryan JF, O’Riordan KJ, Cowan CSM, et al. The Microbiota-Gut-Brain Axis. Physiol Rev. 2019;99:1877–16.
   Google Scholar
• Davis BC, Bajaj JS. Effects of Alcohol on the Brain in Cirrhosis: beyond Hepatic Encephalopathy. Alcohol Clin Exp Res. 2018;42(4):660–667. doi:10.1111/acer.13605.
   Google Scholar
• Vilstrup H, Amodio P, Bajaj J, et al. Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver. Hepatology. 2014;60(2):715–735. doi:10.1002/hep.27210.
   Google Scholar
• Acharya C, Bajaj JS. Current Management of Hepatic Encephalopathy. Am J Gastroenterol. 2018;113(11):1600–1612.
   Google Scholar
• Weissenborn K, Ennen JC, Schomerus H, Ruckert N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol. 2001;34:768–773.
   Google Scholar
• Bajaj JS, Fagan A, White MB, et al. Specific Gut and Salivary Microbiota Patterns Are Linked With Different Cognitive Testing Strategies in Minimal Hepatic Encephalopathy. Am J Gastroenterol. 2019;114(7):1080–1090. doi:10.14309/ajg.0000000000000102.
   Google Scholar
• Ahluwalia V, Betrapally NS, Hylemon PB et al. Impaired Gut-Liver-Brain Axis in Patients with Cirrhosis. Sci Rep. 2016;6(1):26800. doi:10.1038/srep26800.
   Google Scholar
• Valles-Colomer M, Falony G, Darzi Y et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat Microbiol. 2019;4(4):623–632. doi:10.1038/s41564-018-0337-x.
   Google Scholar
• Vieira-Silva S, Falony G, Darzi Y et al. Species-function relationships shape ecological properties of the human gut microbiome. Nat Microbiol. 2016;1(8):16088. doi:10.1038/nmicrobiol.2016.88.
   Google Scholar
• Garavan H, Ross TJ, Stein EA. Right hemispheric dominance of inhibitory control: an event-related functional MRI study. Proc Natl Acad Sci U S A. 1999;96(14):8301–8306. doi:10.1073/pnas.96.14.8301.
   Google Scholar
• Bajaj JS, Hafeezullah M, Franco J et al. Inhibitory control test for the diagnosis of minimal hepatic encephalopathy. Gastroenterology. 2008;135(5):1591–600 e1. doi:10.1053/j.gastro.2008.07.021.
   Google Scholar
• Allampati S, Duarte-Rojo A, Thacker LR et al. Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: a Multicenter US-Based, Norm-Based Study. Am J Gastroenterol. 2016;111(1):78–86. doi:10.1038/ajg.2015.377.
   Google Scholar
• Bajaj JS, Sikaroodi M, Shamsaddini A, et al. Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy. Gut. 2020;70(6):1162–1173.
   Google Scholar
• Martin M Cutadapt Removes Adapter Sequences from High-Throughput Sequencing Reads. https://doi.org/10.14806/ej.17.1.200.
   Google Scholar
• O’Leary NA, Wright MW, Brister JR, et al. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res. 2016;44(D1):D733–45. doi:10.1093/nar/gkv1189.
   Google Scholar
• Al-Ghalith G, Knights D. BURST enables optimal exhaustive DNA alignment for big data. 2017. https://doi.org/10.1101/2020.09.08.287128
   Google Scholar
• Oksanen J, Blanchet FG, Friendly M, et al. vegan: community Ecology Package. R package version. 2019.
   Google Scholar
• [Accessed 20 May 2021]. https://huttenhower.sph.harvard.edu/maaslin/
   Google Scholar
• Shamsaddini A, Dadkhah K, Gillevet PM. BiomMiner: an advanced exploratory microbiome analysis and visualization pipeline. PLoS One. 2020;15(6):e0234860. doi:10.1371/journal.pone.0234860.
   Google Scholar
• Bajaj JS, Kassam Z, Fagan A, et al. Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: a Randomized Clinical Trial. Hepatology. 2017;66(6):1727–1738. doi:10.1002/hep.29306.
   Google Scholar
• Bajaj JS, Saeian K, Christensen KM, et al. Probiotic yogurt for the treatment of minimal hepatic encephalopathy. Am J Gastroenterol. 2008;103(7):1707–1715. doi:10.1111/j.1572-0241.2008.01861.x.
   Google Scholar
• Bass NM, Mullen KD, Sanyal A, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071–1081. doi:10.1056/NEJMoa0907893.
   Google Scholar
• Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology. 2007;45(3):549–559. doi:10.1002/hep.21533.
   Google Scholar
• Hatton G, Shawcross DL. Is treating the gut microbiome the key to achieving better outcomes in cirrhosis? Expert Rev Gastroenterol Hepatol. 2019;13(1):1–2. doi:10.1080/17474124.2019.1543587.
   Google Scholar
• Goldbecker A, Weissenborn K, Hamidi Shahrezaei G, et al. Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates. Gut. 2013;62(10):1497–1504. doi:10.1136/gutjnl-2012-303262.
   Google Scholar
• Rehm J, Gmel GE Sr., Gmel G, et al. The relationship between different dimensions of alcohol use and the burden of disease-an update. Addiction. 2017;112(6):968–1001. doi:10.1111/add.13757.
   Google Scholar
• Solinas A, Piras MR, Deplano A. Cognitive dysfunction and hepatitis C virus infection. World J Hepatol. 2015;7(7):922–925. doi:10.4254/wjh.v7.i7.922.
   Google Scholar
• Ponziani FR, Putignani L, Paroni Sterbini F, et al. Influence of hepatitis C virus eradication with direct-acting antivirals on the gut microbiota in patients with cirrhosis. Aliment Pharmacol Ther. 2018;48(11–12):1301–1311. doi:10.1111/apt.15004.
   Google Scholar
• Perez-Matute P, Iniguez M, Villanueva-Millan MJ, et al. Short-term effects of direct-acting antiviral agents on inflammation and gut microbiota in hepatitis C-infected patients. Eur J Intern Med. 2019;67:47–58. doi:10.1016/j.ejim.2019.06.005.
   Google Scholar
• Ticinesi A, Tana C, Nouvenne A, Prati B, Lauretani F, Meschi T. Gut microbiota, cognitive frailty and dementia in older individuals: a systematic review. Clin Interv Aging. 2018;13:1497–1511. doi:10.2147/CIA.S139163.
   Google Scholar
• Bajaj JS. Alcohol, liver disease and the gut microbiota. Nat Rev Gastroenterol Hepatol. 2019;16(4):235–246. doi:10.1038/s41575-018-0099-1.
   Google Scholar
• Northoff G, Hirjak D, Wolf RC, Magioncalda P, Martino M. All roads lead to the motor cortex: psychomotor mechanisms and their biochemical modulation in psychiatric disorders. Mol Psychiatry. 2021;26(1):92–102. doi:10.1038/s41380-020-0814-5.
   Google Scholar
• Verbruggen F, Best M, Bowditch WA, Stevens T, McLaren IP. The inhibitory control reflex. Neuropsychologia. 2014;65:263–278. doi:10.1016/j.neuropsychologia.2014.08.014.
   Google Scholar
• TG Dinan, RM Stilling, Stanton C,et al. Collective unconscious: how gut microbes shape human behavior. J Psychiatr Res. 2015;63:1–9. doi:10.1016/j.jpsychires.2015.02.021.
   Google Scholar
• Strandwitz P, Kim KH, Terekhova D, et al. GABA-modulating bacteria of the human gut microbiota. Nat Microbiol. 2019;4(3):396–403. doi:10.1038/s41564-018-0307-3.
   Google Scholar
• Feehily C, Karatzas KA. Role of glutamate metabolism in bacterial responses towards acid and other stresses. J Appl Microbiol. 2013;114(1):11–24. doi:10.1111/j.1365-2672.2012.05434.x.
   Google Scholar
• Forrester MT, Foster MW. Protection from nitrosative stress: a central role for microbial flavohemoglobin. Free Radic Biol Med. 2012;52(9):1620–1633. doi:10.1016/j.freeradbiomed.2012.01.028.
   Google Scholar
• Bosoi CR, Rose CF. Oxidative stress: a systemic factor implicated in the pathogenesis of hepatic encephalopathy. Metab Brain Dis. 2013;28(2):175–178. doi:10.1007/s11011-012-9351-5.
   Google Scholar
• Shah V, Kamath PS. Nitric oxide in liver transplantation: pathobiology and clinical implications. Liver Transpl. 2003;9(1):1–11. doi:10.1053/jlts.2003.36244.
   Google Scholar
• Silva YP, Bernardi A, Frozza RL. The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication. Front Endocrinol (Lausanne). 2020;11:25. doi:10.3389/fendo.2020.00025.
   Google Scholar
• Enge S, Fleischhauer M, Gartner A, et al. Brain-Derived Neurotrophic Factor (Val66Met) and Serotonin Transporter (5-HTTLPR) Polymorphisms Modulate Plasticity in Inhibitory Control Performance Over Time but Independent of Inhibitory Control Training. Front Hum Neurosci. 2016;10:370. doi:10.3389/fnhum.2016.00370.
   Google Scholar
• Robinson OJ, Roiser JP. The Role of Serotonin in Aversive Inhibition: behavioural, Cognitive and Neural Perspectives. Psychopathology Review. 2016;3(1):29–40. doi:10.5127/pr.034013.
   Google Scholar
• Villageliu D, Lyte M. Dopamine production in Enterococcus faecium: a microbial endocrinology-based mechanism for the selection of probiotics based on neurochemical-producing potential. PLoS One. 2018;13(11):e0207038. doi:10.1371/journal.pone.0207038.
   Google Scholar
• Jentsch JD, Pennington ZT. Reward, interrupted: inhibitory control and its relevance to addictions. Neuropharmacology. 2014;76(Pt):B:479–86. doi:10.1016/j.neuropharm.2013.05.022.
   Google Scholar
• Winstanley CA, Olausson P, Taylor JR, Jentsch JD. Insight into the relationship between impulsivity and substance abuse from studies using animal models. Alcohol Clin Exp Res. 2010;34:1306–1318.
   Google Scholar
• Franke T, Deppenmeier U. Physiology and central carbon metabolism of the gut bacterium Prevotella copri. Mol Microbiol. 2018;109(4):528–540. doi:10.1111/mmi.14058.
   Google Scholar
• Bajaj JS, Kakiyama G, Cox IJ, et al. Alterations in gut microbial function following liver transplant. Liver Transpl. 2018;24(6):752–761. doi:10.1002/lt.25046.
   Google Scholar
• Sharma M, Li Y, Stoll ML, Tollefsbol TO. The Epigenetic Connection Between the Gut Microbiome in Obesity and Diabetes. Front Genet. 2019;10:1329. doi:10.3389/fgene.2019.01329.
   Google Scholar
• Parker BJ, Wearsch PA, Veloo ACM, The Genus R-PA. Alistipes: gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health. Front Immunol. 2020;11:906. doi:10.3389/fimmu.2020.00906.
   Google Scholar
• Feehily C, O’Byrne CP, Karatzas KA. Functional gamma-Aminobutyrate Shunt in Listeria monocytogenes: role in acid tolerance and succinate biosynthesis. Appl Environ Microbiol. 2013;79(1):74–80. doi:10.1128/AEM.02184-12.
   Google Scholar
• Lima WC, Varani AM, Menck CF. NAD biosynthesis evolution in bacteria: lateral gene transfer of kynurenine pathway in Xanthomonadales and Flavobacteriales. Mol Biol Evol. 2009;26(2):399–406. doi:10.1093/molbev/msn261.
   Google Scholar
• Boersch M, Rudrawar S, Grant G, Zunk M. Menaquinone biosynthesis inhibition: a review of advancements toward a new antibiotic mechanism. RSC Advances. 2018;8(10):5099–5105. doi:10.1039/C7RA12950E.
   Google Scholar
• Farhadi Moghadam B, Fereidoni M. Neuroprotective effect of menaquinone-4 (MK-4) on transient global cerebral ischemia/reperfusion injury in rat. PLoS One. 2020;15(3):e0229769. doi:10.1371/journal.pone.0229769.
   Google Scholar
• Arnoriaga-Rodriguez M, Mayneris-Perxachs J, Burokas A, et al. Gut bacterial ClpB-like gene function is associated with decreased body weight and a characteristic microbiota profile. Microbiome. 2020;8(1):59. doi:10.1186/s40168-020-00837-6.
   Google Scholar
• Bajaj JS, Kassam Z, Fagan A, et al. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: a randomized clinical trial. Hepatology. 2017;66:1727–1738.
   Google Scholar
• Bajaj JS, Salzman NH, Acharya C, et al. Fecal Microbial Transplant Capsules are Safe in Hepatic Encephalopathy: a Phase 1, Randomized, Placebo-Controlled Trial. Hepatology. 2019;70(5):1690–1703.
   Google Scholar
• Bajaj JS, Gavis EA, Fagan A, et al. A Randomized Clinical Trial of Fecal Microbiota Transplant for Alcohol Use Disorder. Hepatology. 2020;73:S59–S60. doi:10.1016/S0168-8278(20)30660-7.
   Google Scholar